163 related articles for article (PubMed ID: 24549600)
21. Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis.
Dovio A; Generali D; Tampellini M; Berruti A; Tedoldi S; Torta M; Bonardi S; Tucci M; Allevi G; Aguggini S; Bottini A; Dogliotti L; Angeli A
Osteoporos Int; 2008 Jan; 19(1):113-7. PubMed ID: 17703272
[TBL] [Abstract][Full Text] [Related]
22. [Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease].
Xu DR; Su C; Zou WY; Xu HR; Huang S; Li J; Luo SK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):376-80. PubMed ID: 20416172
[TBL] [Abstract][Full Text] [Related]
23. Serum osteoprotegrin (OPG) and receptor activator of nuclear factor kappaB (RANKL) in healthy children and adolescents.
Wasilewska A; Rybi-Szuminska AA; Zoch-Zwierz W
J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1099-104. PubMed ID: 20333868
[TBL] [Abstract][Full Text] [Related]
24. Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density.
Hamed EA; Mohamed NA; El-Metwally TH; Kamal MM
J Pediatr Hematol Oncol; 2010 May; 32(4):267-73. PubMed ID: 20445416
[TBL] [Abstract][Full Text] [Related]
25. Maintained malnutrition produces a progressive decrease in (OPG)/RANKL ratio and leptin levels in patients with anorexia nervosa.
Muñoz-Calvo MT; Barrios V; García de Alvaro MT; Lefort M; Méndez-Dávila C; Argente J; de la Piedra C
Scand J Clin Lab Invest; 2007; 67(4):387-93. PubMed ID: 17558893
[TBL] [Abstract][Full Text] [Related]
26. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
Baek KH; Oh KW; Lee WY; Tae HJ; Rhee EJ; Han JH; Cha BY; Kim YJ; Lee KW; Son HY; Kang SK; Kim CC; Kang MI
Bone; 2006 Dec; 39(6):1352-60. PubMed ID: 16905375
[TBL] [Abstract][Full Text] [Related]
27. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
Todenhöfer T; Hennenlotter J; Leidenberger P; Wald A; Hohneder A; Kühs U; Mischinger J; Aufderklamm S; Gakis G; Blumenstock G; Stenzl A; Schwentner C
BJU Int; 2014 Jan; 113(1):152-9. PubMed ID: 23360112
[TBL] [Abstract][Full Text] [Related]
28. Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis.
Ozkaya O; Buyan N; Bideci A; Gonen S; Ortac E; Fidan K; Cinaz P; Söylemezoğlu O
Nephron Clin Pract; 2007; 105(4):c153-8. PubMed ID: 17259742
[TBL] [Abstract][Full Text] [Related]
29. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
Kim HR; Lee SH; Kim HY
Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
[TBL] [Abstract][Full Text] [Related]
31. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer.
Mikosch P; Igerc I; Kudlacek S; Woloszczuk W; Gallowitsch HJ; Kresnik E; Stettner H; Grimm G; Lind P; Pietschmann P
Eur J Clin Invest; 2006 Aug; 36(8):566-73. PubMed ID: 16893379
[TBL] [Abstract][Full Text] [Related]
32. Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.
Kraj M; Owczarska K; Sokołowska U; Centkowski P; Pogłód R; Kruk B
Arch Immunol Ther Exp (Warsz); 2005; 53(5):454-64. PubMed ID: 16314829
[TBL] [Abstract][Full Text] [Related]
33. Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients.
Naumnik B; Klejna K; Koc-Żórawska E; Myśliwiec M
Adv Med Sci; 2013; 58(2):382-7. PubMed ID: 23959668
[TBL] [Abstract][Full Text] [Related]
34. Relationship between insulin resistance, hs-CRP, and body fat and serum osteoprotegerin/RANKL in prediabetic patients.
Bilgir O; Yavuz M; Bilgir F; Akan OY; Bayindir AG; Calan M; Bozkaya G; Yuksel A
Minerva Endocrinol; 2018 Mar; 43(1):19-26. PubMed ID: 28146138
[TBL] [Abstract][Full Text] [Related]
35. The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa.
Ohwada R; Hotta M; Sato K; Shibasaki T; Takano K
Endocr J; 2007 Dec; 54(6):953-9. PubMed ID: 17998762
[TBL] [Abstract][Full Text] [Related]
36. Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?
Kananen K; Volin L; Laitinen K; Ruutu T; Välimäki MJ
Osteoporos Int; 2006; 17(5):724-30. PubMed ID: 16437190
[TBL] [Abstract][Full Text] [Related]
37. [Concentration measurement of the OPG and sRANKL of peripheral blood among normal healthy people].
Zhu LL; Bao NR; Zhou LW; Guo T; Zeng XF; Zhao JN
Zhongguo Gu Shang; 2010 Feb; 23(2):87-9. PubMed ID: 20345025
[TBL] [Abstract][Full Text] [Related]
38. Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes.
Mou YK; Zhang PP; Li QX; Lin ZM; Liao ZT; Wei QJ; Gu JR
Clin Rheumatol; 2015 Jun; 34(6):1085-9. PubMed ID: 25912212
[TBL] [Abstract][Full Text] [Related]
39. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
[TBL] [Abstract][Full Text] [Related]
40. Associations between bone, fat tissue and metabolic control in children and adolescents with type 1 diabetes mellitus.
Wędrychowicz A; Stec M; Sztefko K; Starzyk JB
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):491-5. PubMed ID: 24918536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
